Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio 1 Year Total Returns (Daily) : 254.2% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 254.2% |
| August 20, 2026 | 242.2% |
| August 19, 2026 | 273.5% |
| August 18, 2026 | 235.5% |
| August 17, 2026 | 251.8% |
| August 14, 2026 | 289.0% |
| August 13, 2026 | 296.0% |
| August 12, 2026 | 311.7% |
| August 11, 2026 | 312.0% |
| August 10, 2026 | 291.0% |
| August 07, 2026 | 295.3% |
| August 06, 2026 | 283.5% |
| August 05, 2026 | 268.2% |
| August 04, 2026 | 277.1% |
| August 03, 2026 | 272.7% |
| July 31, 2026 | 328.2% |
| July 30, 2026 | 318.5% |
| July 29, 2026 | 324.3% |
| July 28, 2026 | 300.9% |
| July 27, 2026 | 308.8% |
| July 24, 2026 | 289.1% |
| July 23, 2026 | 287.3% |
| July 22, 2026 | 325.5% |
| July 21, 2026 | 357.2% |
| July 20, 2026 | 385.8% |
| Date | Value |
|---|---|
| July 17, 2026 | 351.4% |
| July 16, 2026 | 361.6% |
| July 15, 2026 | 387.0% |
| July 14, 2026 | 376.5% |
| July 13, 2026 | 389.0% |
| July 10, 2026 | 396.5% |
| July 09, 2026 | 343.3% |
| July 08, 2026 | 283.3% |
| July 07, 2026 | 475.4% |
| July 06, 2026 | 490.6% |
| July 02, 2026 | 512.2% |
| July 01, 2026 | 503.2% |
| June 30, 2026 | 491.7% |
| June 29, 2026 | 503.6% |
| June 26, 2026 | 451.7% |
| June 25, 2026 | 460.3% |
| June 24, 2026 | 437.8% |
| June 23, 2026 | 529.2% |
| June 22, 2026 | 549.7% |
| June 18, 2026 | 512.2% |
| June 17, 2026 | 488.8% |
| June 16, 2026 | 464.6% |
| June 15, 2026 | 513.4% |
| June 12, 2026 | 502.7% |
| June 11, 2026 | 458.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Q32 Bio, Inc. | 751.7% |
| Beam Therapeutics, Inc. | 85.88% |
| C4 Therapeutics, Inc. | 53.26% |
| Cullinan Therapeutics, Inc. | 182.7% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |